AGA
LLY icon

Arkos Global Advisors’s Eli Lilly LLY Stock Holding History

Arkos Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$367K Sell
306
-191
-38% -$195K 0.04% 89
2026
Q1 		$457K Buy
497
+19
+4% +$19.3K 0.06% 76
2025
Q4 		$514K Sell
478
-708
-60% -$677K 0.07% 72
2025
Q3 		$905K Buy
1,186
+775
+189% +$577K 0.12% 51
2025
Q2 		$320K Buy
411
+10
+2% +$7.77K 0.04% 99
2025
Q1 		$331K Buy
+401
New +$334K 0.05% 94
2024
Q4 		– Sell
-228
Closed -$202K – 136
2024
Q3 		$202K Sell
228
-48
-17% -$43.2K 0.03% 125
2024
Q2 		$250K Sell
276
-25
-8% -$20K 0.04% 111
2024
Q1 		$234K Buy
+301
New +$214K 0.04% 130

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arkos Global Advisors's LLY Position: Q2 2026 in Review

Arkos Global Advisors reduced its Eli Lilly (LLY) stake by 38% in Q2 2026, selling an estimated $195K and leaving 306 shares worth $367K. The position accounts for 0.04% of the portfolio, ranked #89.

Arkos Global Advisors first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $905K in Q3 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Arkos Global Advisors held 306 shares of Eli Lilly worth $367K as of Q2 2026.
  • Arkos Global Advisors sold 191 Eli Lilly shares in Q2 2026, an estimated $195K.
  • Eli Lilly made up 0.04% of Arkos Global Advisors's portfolio in Q2 2026, its #89 holding.
  • Arkos Global Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Arkos Global Advisors's Eli Lilly position peaked at $905K in Q3 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Arkos Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.